GlycoMimetics discloses $2M deposit at Silicon Valley Bank; says amount immaterial

CRESCENT BIOPHARMA, INC.

Company holds approximately $2M in cash deposits at Silicon Valley Bank.
GlycoMimetics considers the deposit amount immaterial to its overall liquidity.
Disclosure filed March 10, 2023, amid SVB's collapse.

item 7.01

CRESCENT BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001558370-23-003498

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.